Incidence and risk factors of serious infections occurred in patients with lung cancer following immune checkpoint blockade therapy. Wang X, Wu YX, Hu WP, Zhang J, et al. BMC Cancer 2025;25:307.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Wu YX, Hu WP, Zhang J, et al. Incidence and risk factors of serious infections occurred in patients with lung cancer following immune checkpoint blockade therapy. BMC Cancer 2025;25:307.
PMID: 39979857